Table 3.

Tumors showing stable disease after therapy

YM155 dose (mg/m2/d)Tumor typeNo. of completed cycles
1.8MFH4
Thymoma6
3.6NSCLC3
Synovial sarcoma4
4.8NSCLC3
Thymic2
6.0Thyroid6
10.6Esophageal leiomyosarcoma3
Thyroid19